Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002046326 | SCV002315021 | uncertain significance | not provided | 2022-07-27 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 2623 of the PCLO protein (p.Val2623Gly). This variant is present in population databases (rs776949129, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with PCLO-related conditions. ClinVar contains an entry for this variant (Variation ID: 1521543). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ce |
RCV002046326 | SCV004162380 | likely benign | not provided | 2024-10-01 | criteria provided, single submitter | clinical testing | PCLO: BP4 |
Breakthrough Genomics, |
RCV002046326 | SCV005195689 | uncertain significance | not provided | criteria provided, single submitter | not provided |